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H
ow does society protect some of its most vulnerable and
disadvantaged patients while respecting individual
autonomy? This is the dilemma facing many Canadian juris-
dictions as they consider the extension of compulsory treat-
ment to community settings. Canada is not unique but part of a
trend to enforce outpatient treatment in many jurisdictions,
including Australia, New Zealand, the United States, and the
European Union (1,2). What is the basis for this enthusiasm?
Certainly, research published in this journal has endorsed the
measure to varying degrees (3), as does the position paper of
the Canadian Psychiatric Association (4). We wonder
whether this confidence is misplaced, and we critically exam-
ine several troubling aspects of the literature on CTOs.
Opinion Is Not Evidence
One approach to the evaluation of CTOs has been to ask prac-
tising psychiatrists for their opinion on the utility of the
orders (3). These suggest general support for the measure.
However, surveys of psychiatrists’ views on CTOs provide
only Level 3 evidence, in contrast to the Level 1 evidence
from appropriately conducted RCTs and the Level 2 evidence
from well-designed non-RCT studies, such as case–control
studies or interrupted time series. Such surveys have little
place in an era of evidence-based practice and, in the absence
of other data, would not be accepted as a reason to introduce
any other psychiatric intervention.
No Controls, Little Evidence
Early uncontrolled studies, largely from the United States,
suggested that patients on CTOs had reduced rates of
rehospitalization and shorter stays in hospital, associated with
increased compliance. However, there were no significant
differences between the 2 groups when control subjects not
subject to a compulsory treatment order were included (5–7).
The weakness of uncontrolled designs is the difficulty in
determining the reason for any change in outcome. Aside
from the effect of the intervention, other possible explanations
include regression to the mean, other treatment, life events, or
changes in social circumstances. These often overestimate the
effect of the intervention of interest.
Controlled studies without randomization also have short-
comings. There may always be another reason why patients
were placed on treatment and the control subjects were not.
They may be less insightful about their illness or more likely
to have a history of aggressive behaviour. Only one matched
control study controlled for forensic history (7).
What About RCTs?
RCTs address many of these problems but are very difficult to
conduct where mental health legislation policy is imple-
mented at a state, provincial, or national level. There have
therefore only been 2 RCTs, and both were in the United
States (New York and North Carolina) (8–11). These trials
have been the subject of much debate in terms of subjects,
design, analysis, and generalizability.
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Selection and Follow-Up Bias:
Were the Patients Typical?
Both RCTs excluded patients with a history of violence from
randomization. Although understandable from an ethical and
legal standpoint, this limits their applicability because recent
dangerousness, particularly violence against others, is often
the reason for compulsory treatment in hospital or in the com-
munity. One study did include a nonrandomized violent sub-
group in the analysis, but this negates the whole point of an
RCT (see below) (9–11).
Selection bias was further compounded by high dropout rates.
Of the 577 patients identified as eligible for participation in
the New York and North Carolina studies, including the vio-
lent subgroup, only 292 (51%) were followed up 1 year later.
Although the North Carolina study had a higher completion
rate among randomized patients than the New York study
(82% and 45%, respectively), data were not available for all
patients for all of the outcomes. The 1-year follow-up is there-
fore of a highly selected and potentially unrepresentative pop-
ulation that was not dangerous and was sufficiently compliant
to participate in baseline and follow-up assessments.
Limited Generalizability:
Was the Intervention Typical?
Aside from bias, the generalizability of these studies is further
compromised by the fact they are studies of court-ordered out-
patient committal in the United States. This is in contrast to the
rest of the English-speaking world, where the intervention is
prescribed by clinicians. The results may therefore not be
generalizable to other jurisdictions. Court involvement in
making the order may, in itself, affect treatment compliance.
We simply do not know.
Design and Analysis:
When Is an RCT Not an RCT?
Neither study showed significant differences between inter-
vention and control groups in terms of hospital or other out-
comes such as arrests, homelessness, or compliance with
treatment over the following 12 months (2,8–11); nor were
there any significant differences between the CTO and control
groups in psychiatric symptoms or quality of life measured by
standardized instruments (8).
The New York study did find that patients randomized to
CTOs spent an average of 43 days in hospital in the follow-up
period, compared with 101 days for the group discharged
without a treatment order (8). Although a large difference, it
did not reach statistical significance, possibly because of
small numbers (n = 152). There was also a suggestion that
members of the control group and their case managers thought
that they were actually on CTOs. Both these factors would
minimize any effect of the intervention. However, the larger
study from North Carolina (n = 264) also did not find any sta-
tistically significant differences in hospital or other outcomes
between the intervention and control groups (9–11). Further,
combining the results from the New York and North Carolina
studies in a metaanalysis, which would help address insuffi-
cient power in either study, made no difference to the
results (2).
Controversially, the North Carolina researchers supple-
mented their RCT with nonrandomized data that did show a
difference between some groups on CTOs and the control
group. In the first instance, they performed a post hoc analysis
of a nonrandom sample (n = 47) that underwent sustained
periods (more than 180 days) of outpatient commitment
beyond that of the initial court order. This group had about
57% fewer readmissions and 20 fewer hospital days than the
control subjects. The group also had improved outcomes in
terms of compliance with medication, homelessness, and
forensic history (9–11). However, such analyses are subject to
the bias and confounding that randomized trials are designed
to minimize. Analysis of subjects who have not been ran-
domly assigned to CTO groups of less or more than 180 days
may reflect a bias where a CTO was selectively extended
when it seemed to be helping the patient.
In the second instance, the North Carolina researchers
included a nonrandom sample of violent patients who
received the intervention and were excluded from the RCT;
they then ran a series of multivariate analyses of various out-
comes. Again, although interesting, this is not RCT evidence.
Are There Any Outcomes for Which
Compulsory Community Treatment May
Make a Difference?
Controlled and RCT designs have shown that patients on
CTOs have greater outpatient contact with mental health ser-
vices than do control subjects in some circumstances (6,11).
However, this is not really an outcome measure because it
relates to the process of the intervention itself (2). If patients
are compelled to attend outpatient appointments, it is not sur-
prising that outpatient contacts will increase. It is a bit like
measuring the efficacy of an antihypertensive medication by
assessing patient adherence rather than the effect on blood
pressure. Importantly, all this increased contact does not
translate into meaningful change in terms of improved
symptomatology or compliance with medication (2).
Conclusions
Proponents of CTOs argue that they are less coercive than the
alternatives of compulsory admission to hospital or arrest.
However, research findings suggest that CTOs remain an
unproven way of reducing either when subjects are compared
with matched or randomly selected control subjects. Further,
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these negative findings cannot be blamed on insufficient
study power because they persisted when studies were com-
bined in metaanalyses (2).
There have been 2 responses to this lack of evidence. One
response is to say that we should expect CTOs to actually
increase readmission rates through increased surveillance.
Earlier and more frequent admissions could then lead to better
outcome in terms of reduced lengths of stay. The other
response is to argue that admission rates are not a relevant out-
come at all and that other indicators are more appropriate.
Unfortunately, the evidence on outcomes such as length of
stay, symptomatology, homelessness, quality of life, or per-
ceived coerciveness is no better (2). This is truly the case of
the emperor (or in this case, the treatment) having no clothes.
We should be investing our energies in less coercive alterna-
tives, such as assertive community treatment and advance
directives for psychiatric care, where research findings show
greater promise.
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